Abstract
The advent of recombinant-DNA technology provides the prospect of synthesis of human growth hormone (hGH) in unlimited quantitites. Since 1% of protein synthesized by Escherichia coli by this procedure is hGH, the estimated yields are predicted to be substantial. The details of isolation of the mRNA and transcription of the DNA for hGH have been described earlier.(1–3) hGH has been cloned as a methionyl analogue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D. V. Goeddel, H. L. Hyeneker, T. Hozum, R. Arentzen, K. Itakura, D. G. Yansura, M. J. Ross, G. Miozzari, R. Crea, and P. H. Seeburg, Direct expression in Eschericia coli of a DNA sequence coding for human growth hormone, Nature 281:544–548, 1979.
J. H. Martial, R. A. Hallewell, J. D. Baxter, and H. M. Goodman, Human growth hormone: Complementary DNA cloning and expression in bacteria, Science 205:602–607, 1979.
K. C. Olson, J. Fenno, N. Lin, R. N. Harkins, C. Snider, W. H. Kohr, M.J. Ross, D. Fodge, G. Prender, and N. Stebbing, Purified growth hormone from E. coli is biologically active, Nature 293:408–411, 1981.
R. G. Rosenfeld, B. B. Aggarwal, R. L. Hintz, and L. A. Dollar, Recombinant DNA-derived methionyl human growth hormone is similar in membrane binding properties to human pituitary growth hormone, Biochem. Biophys. Res. Commun. 106:202–209, 1982.
L. G. Frigeri, G. Robel, and N. Stebbing, Bacteria-derived human growth hormone lacks lipolytic activity in rat adipose tissue, Biochem. Biophys. Res. Commun. 104:1041–1046, 1982.
K. Takano, N. Hizuka, K. Shizume, K. Asakawa, and M. Kogawa, Short-term study of biosynthesized hGH in man, Endocrinol. Japan 30:(l):79–84, 1983.
R. L. Hintz, R. G. Rosenfeld, D. M. Wilson, A. Bennett, J. Finno, B. McClellan, and R. Swift, Biosynthetic methionyl human growth hormone is biologically active in adult man, Lancet 1:1276–1279, 1982.
R. G. Rosenfeld, D. M. Wilson, L. A. Dollar, A. Bennett, and R. Hintz, Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site, J. Clin. Endocrinol. Metab. 54:1033–1038, 1982.
L. E. Underwood, S. J. Voina, and J. J. Van Wyk, Restoration of growth by human growth hormone (Roos) in hypopituitary dwarfs immunized by other human growth hormone preparations: Clinical and ummunological studies, Clin. Endocrinol. Metab. 38:288–297, 1974.
H. G. Goodman, M. M. Grumbach, and S. L. Kaplan, Growth and growth hormone. II. A comparison of isolated growth-hormone deficiency and multiple pituitary-hormone deficiencies in 35 patients with idiopathic hypopituitary dwarfism, N. Engl. J. Med. 278:57–68, 1968.
M. A. Preece, J. M. Tanner, R. H. Whitehouse, and N. Cameron, Dose dependence of growth response to human growth hormone in growth hormone deficiency, J. Clin. Endocrinol. Metab. 42:477–483, 1976.
S. D. Frasier, Human pituitary growth hormone (HGH) therapy in growth hormone deficiency, Endocrine Rev. 4:155–170, 1983.
T. Aceto, Jr., S. D. Frasier, A. B. Hayles, H. I. L. Meyer-Bahlburg, M. L. Parker, R. Munschauer, and G. Di Chiro, Collaborative study of the effects of human growth hormone in growth hormone deficiency. I. First year of therapy, J. Clin. Endocrinol. Metab. 35:483–496, 1972.
D. M. Bergenstal, and M. B. Lipsett, Metabolic effects of human growth hormone and growth hormone of other species in man, J. Clin. Endocrinol. Metab. 20:1427–1436, 1960.
A.J. D’Ercole, M. D. Underwood, and J. J. Van Wyk, Serum somatomedin-C in hypopituitarism and in other disorders of growth, J. Pediatr. 90:375–381, 1977.
K. C. Copeland, L. E. Underwood, and J. J. Van Wyk, Induction of immunoreactive somatomedin C in human serum by growth hormone: dose-response relationships and effect of chromatographic profiles, J. Clin. Endocrinol. Metab. 50:690–697, 1980.
R. G. Rosenfeld, S. F. Kemp, and R. L. Hintz, Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate, J. Clin. Endocrinol. Metab. 53:611–617, 1981.
S. L. Blethen, W. H. Daughaday, and V. V. Weldon, Kinetics of the somatomedin C/insulin-like growth factor I: Response to exogenous growth hormone (GH) in GH deficient children, J. Clin. Endocrinol. Metab. 54:986–990, 1982.
L. A. Frohman, M. H. MacGillivray, and T. Aceto, Jr., Acute effects of human growth hormone on insulin secretion and glucose utilization in normal and GH deficient states, J. Clin. Endocrinol. Metab. 27:561–567, 1967.
H. Gold, S. Spector, N. A. Samaan, and O. Pearson, Effect of growth hormone on carbohydrate metabolism in hypopituitary dwarfs, Metabolism 17:74–83, 1983.
G. Costin, M. D. Kogut, and S. D. Frasier, Effect of low dose human growth hormone on carbohydrate metabolism in children with hypopituitarism, J. Pediatr. 80:796–803, 1972.
L. E. Underwood, J. L. Van der Brande, G. J. Anthony, S. J. Voina, and J. J. Van Wyk, Islet cell function and glucose homeostasis in hypopituitary dwarfism: Synergism between growth hormone and cortisone, J. Pediatr. 82:28–37, 1973.
B. M. Lippe, S. A. Kaplan, M. P. Golden, S. A. Hendricks, and M. L. Scott, Carbohydrate tolerance and insulin binding in children with hypopituitarism: Response after acute and chronic human growth hormone administration, J. Clin. Endocrinol. Metab. 53:507–513, 1981.
A. W. Root, A. M. Bongiovanni, and W. R. Eberlein, Inhibition of thyroidal radioiodine uptake by human growth hormone, J. Pediatr. 76:422–429, 1970.
B. A. Porter, S. Refetoff, R. L. Rosenfeld, L. J. De Groot, V. S. Fang, and V. Stark, Abnormal thyroxine metabolism in hyposomatotrophic dwarfism and inhibition of responsiveness to TRH during GH therapy, Pediatrics 51:668–674.
B. M. Lippe, A. J. Van Herle, S. H. La Franchi, R. P. Uller, N. Lavin, and S. A. Kaplan, Reversible hypothyroidism in growth hormone deficient children treated with human growth hormone, J. Clin. Endocrinol. Metab. 40:612–618, 1975.
A. Prader, J. Szeky, H. Wagner, R. Illig, J. L. Touber, and D. Maingoy, Acquired resistance to human growth hormone caused by specific antibodies, Lancet 2:378–382, 1964.
R. Illig, Growth hormone antibodies in patients treated with different preparations of human growth hormone (HGH), J. Clin. Endocrinol. 31:679–688, 1970.
S. L. Kaplan, D. C. L. Savage, S. Suter, R. Wolter, and M. M. Grumbach, Antibodies to human growth hormone arising in patients treated with human growth hormone: incidence, characteristics, and effects on growth, in: Advances in Human Growth Hormone Research; A Symposium, U. S. Department of Health, Education and Welfare, Publication No. NIH 74–612, 725747, 1974.
S. D. Frasier, T. Aceto Jr., A. B. Hayles, M. L. Parker, and H. F. L. Meyer-Bahlburg, Collaborative study of the effects of human growth hormone in growth hormone deficiency. II. Development and significance of antibodies to human growth hormone during the first year of therapy, J. Clin. Endocrinol. Metab. 38:14–18, 1974.
W. V. Moore and P. Leppert, Role of aggregated human growth hormone (hGH) in development of antibodies to hGH, J. Clin. Endocrinol. Metab. 51:691–697, 1980.
O. Westphal and P. Roos, Treatment of pituitary dwarfism with human growth hormone, Acta. Paediatr. Scand 182(Suppl):52–81, 1968.
G. Van Vliet, D. M. Styne, S. L. Kaplan, and M. M. Grumbach, Growth hormone treatment for short stature, New Engl. J. Med. 309:1016–1022, 1983.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Publishing Corporation
About this chapter
Cite this chapter
Kaplan, S.L. et al. (1986). Clinical Studies with Recombinant-DNA-Derived Methionyl-Human Growth Hormone in Growth Hormone-Deficient Children. In: Raiti, S., Tolman, R.A. (eds) Human Growth Hormone. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7201-5_22
Download citation
DOI: https://doi.org/10.1007/978-1-4615-7201-5_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-7203-9
Online ISBN: 978-1-4615-7201-5
eBook Packages: Springer Book Archive